MY148488A - Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists - Google Patents

Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists

Info

Publication number
MY148488A
MY148488A MYPI20050606A MY148488A MY 148488 A MY148488 A MY 148488A MY PI20050606 A MYPI20050606 A MY PI20050606A MY 148488 A MY148488 A MY 148488A
Authority
MY
Malaysia
Prior art keywords
additional
receptor antagonists
glutamate receptor
metabotropic glutamate
compounds
Prior art date
Application number
Inventor
Edwards Louise
Stefanec Tomislav
Stormann Thomas
Wensbo David
Tao Xin
Jalaj Arora
Isaac Methvin
Johansson Martin
Kers Annika
Malmberg Johan
Mcleod Donald
Minidis Alexander
Staaf Karin
Slassi Abdelmalik
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of MY148488A publication Critical patent/MY148488A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

THE PRESENT INVENTION RELATES TO NEW COMPOUNDS OF FORMULA I, TO PHARMACEUTICAL FORMULATIONS CONTAINING THE COMPOUNDS, AND TO THE USE OF THE COMPOUNDS IN THE PREVENTION AND/OR TREATMENT OF mGluR5 RECEPTOR-MEDIATED DISORDERS.
MYPI20050606 2004-02-18 2005-02-17 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists MY148488A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77986804A 2004-02-18 2004-02-18

Publications (1)

Publication Number Publication Date
MY148488A true MY148488A (en) 2013-04-30

Family

ID=36940522

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20050606 MY148488A (en) 2004-02-18 2005-02-17 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists

Country Status (2)

Country Link
AR (1) AR049472A1 (en)
MY (1) MY148488A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9303024B2 (en) 2011-10-11 2016-04-05 Dana-Farber Cancer Institute, Inc. Pyrazol-3-ones that activate pro-apoptotic BAX
TW201506024A (en) 2013-07-02 2015-02-16 必治妥美雅史谷比公司 Tricyclic carboxamide derivatives as potent ROCK inhibitors
WO2015002926A1 (en) 2013-07-02 2015-01-08 Bristol-Myers Squibb Company Tricyclic pyrido-carboxamide derivatives as rock inhibitors
AR126670A1 (en) * 2021-08-02 2023-11-01 Eurofarma Laboratorios S A N-ACYLYDRAZONIC COMPOUNDS INHIBITORS OF Nav 1.7 AND/OR Nav 1.8, THEIR OBTAINING PROCESSES, COMPOSITIONS, USES, TREATMENT METHODS OF THESE AND KITS

Also Published As

Publication number Publication date
AR049472A1 (en) 2006-08-09

Similar Documents

Publication Publication Date Title
SG146657A1 (en) Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
MX2008001606A (en) Substituted piperazines as metabotropic glutamate receptor antagonists.
JO2355B1 (en) CGRP receptor antagonists
MX2007014405A (en) Novel oxadiazole derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors.
DE602006006712D1 (en) THIAZOLYLPIPERIDINE DERIVATIVES USE AS H3 RECEPTOR MODULATORS
TW200612905A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
GB0504828D0 (en) Therapeutic agents
TW200611702A (en) Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
MXPA06014721A (en) Novel alkynyl derivatives as modulators of metabotropic glutamate receptors.
TW200608960A (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
TW200628452A (en) Substituted 2-anilinopyrimidines as cell-cycle-kinase or receptor-tyrosine-kinase inhibitors, their production and use as pharmaceutical agents
MA28279A1 (en) INDOLE DERIVATIVES AND THE USE THEREOF AS KINASE INHIBITORS, IN PARTICULAR IKK2 INHIBITORS
TW200608966A (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
MXPA06009475A (en) Quinazoline derivatives and therapeutic use thereof.
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
UA92670C2 (en) Pyrazoline compounds as mineralocorticoid receptor antagonists , pharmaceutical use thereof, composition based thereon
MY147677A (en) Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
WO2004087048A3 (en) Benzamide modulators of metabotropic glutamate receptors
ATE467632T1 (en) PYRROLOÄ2,3-BÜPYRIDINE DERIVATIVES AS MODULATORS OF THE H3 RECEPTOR
MX2007006387A (en) 3-substituted pyridine derivatives as h3 antagonists.
TW200505904A (en) Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
MX2007007027A (en) Piperazinyl pyridine derivatives as anti-obesity agents.
GB0524814D0 (en) Compounds
WO2007067875A3 (en) Pyridinyl sulfonamide modulators of chemokine receptors
JO2747B1 (en) Compounds